The Neurotoxicity of MPTP and the Relevance to Parkinson's Disease

This publication has 44 references indexed in Scilit:

• Accumulation of 1-methyl-4 phenylpyridinium (MPP+) into bovine chromaffin granules results in a large restriction of its molecular motion: A 13C and 31P NMR study
  Biochemical and Biophysical Research Communications, 1988
• MPTP and its relevance to parkinson's disease
  Neurochemistry International, 1987
• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde
  Life Sciences, 1987
• V. 4-phenylpyridine (4PP) and MPTP: The relationship between striatal MPP+ concentrations and neurotoxicity
  Life Sciences, 1987
• MPTP induced dopaminergic neurotoxicity—a useful model in the study of parkinson's disease?
  Neurochemistry International, 1987
• Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse
  Neuroscience Letters, 1985
• Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm study
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
• Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse liver preparations
  Biochemical and Biophysical Research Communications, 1984
• I. Parkinson's disease: Studies with an animal model
  Life Sciences, 1984
• The effect of age on the activity and molecular properties of human brain monoamine oxidase
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1980